Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | ($9,940.9K) | ($4,161.3K) | ($1,219.9K) | ($1,825.3K) | $35.9M | $3,880.0K | ($5,766.7K) | ($374.1K) | $11.1M | $22.9M | $10.7M | $13.8M | $16.0M | $14.0M | $26.0M | $14.9M | $42.5M | $133.5M | $133.6M | $47.7M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Repligen Corporation's last 12-month Operating Income is ($5,201.0K), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Repligen Corporation's Operating Income growth was N/A. The average annual Operating Income growth rates for Repligen Corporation have been N/A over the past three years, N/A over the past five years.